Evidence of a polyclonal nature of myositis ossificans

Virchows Arch. 2005 Apr;446(4):438-41. doi: 10.1007/s00428-004-1169-z. Epub 2005 Mar 11.

Abstract

Myositis ossificans is a localized, self-limiting, reparative lesion that is composed of reactive hypercellular fibrous tissue and bone. Although it is clearly a benign lesion, its clinical, radiological, and histological appearance may sometimes mimic a malignant tumor. Whether myositis ossificans represents a monoclonal or polyclonal hyperplastic proliferation is not yet known. To address this question, we therefore extracted DNA from the respective paraffin-embedded tumor tissues of nine women with a median age of 50 years at diagnosis (range: 20-84 years) and studied the X inactivation pattern by means of methylation-sensitive polymerase chain reaction and primers that target the polymorphic CGG trinucleotide repeat of the FMR1 gene. The fact that we did not detect any skewing of the X inactivation pattern in the five successfully analyzed cases corroborates the notion that myositis ossificans results from a polyclonal proliferation and confirms that it is a reactive, reparative process. Analysis of the X inactivation pattern may, thus, supplement the differential diagnostic work-up of cases with an uncertain histology, at least in the informative proportion of female patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Cell Proliferation
  • Clone Cells / pathology*
  • DNA Methylation*
  • Diagnosis, Differential
  • Dosage Compensation, Genetic*
  • Female
  • Humans
  • Middle Aged
  • Myositis Ossificans / genetics
  • Myositis Ossificans / pathology*
  • Myositis Ossificans / surgery
  • Sarcoma / diagnosis
  • Soft Tissue Neoplasms / diagnosis